Investment
Features
FeesSafety
Academy
More
Pluang+

Compare International Paper Company Common Stock (IP) vs Dr. Reddy's Laboratories Ltd Common Stock (RDY) Price & Performance

International Paper Company Common StockTrade
Dr. Reddy's Laboratories Ltd Common StockTrade

Price performance (Past 24H)

Key statistics

International Paper Company Common Stock vs Dr. Reddy's Laboratories Ltd Common Stock — how do they compare? International Paper Company Common Stock trades at $31.95 (market cap $16.85B), while Dr. Reddy's Laboratories Ltd Common Stock trades at $12.75 (market cap $10.78B). The key difference: International Paper Company Common Stock is the larger of the two by market cap, and International Paper Company Common Stock pays the higher dividend (5.82%). Which is the better fit depends on your goals — on Pluang, investors hold International Paper Company Common Stock for 0 Days and Dr. Reddy's Laboratories Ltd Common Stock for 0 Days on average.

IPRDY
Market Cap
$16.85B$10.78B
Volume
3,482,5862,724,343
Sector
Basic MaterialsHealth
52-Week High
$49.19$15.38
52-Week Low
$29.38$11.38
Typical Hold Time
0 Days0 Days
Enterprise Value
$25.81B$10.68B
Dividend Yield
5.82%0.65%

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

IP
100% Buy0% Sell
Avg holding period · 0 Days
RDY
100% Buy0% Sell
Avg holding period · 0 Days

Top news

Latest headlines on both assets

About International Paper Company Common Stock

International Paper Company is a US producer of fiber-based packaging, pulp, and paper products, manufacturing corrugated packaging and containerboard used to ship and protect goods.

Read more on IP →

About Dr. Reddy's Laboratories Ltd Common Stock

Dr. Reddy's Laboratories Ltd. develops and manufactures generic medicines, active pharmaceutical ingredients (APIs), biosimilars, and over-the-counter (OTC) products, headquartered in Hyderabad, India, with therapeutic focus areas spanning gastrointestinal, cardiovascular, oncology, and dermatology.

Read more on RDY →